Changchun Dirui Pharmaceutical

Changchun Dirui Pharmaceutical is a Chinese pharmaceutical company and a wholly-owned subsidiary of Dirui Industrial Co., Ltd., specializing in the manufacture of chemical drugs. Based in Changchun, Jilin Province, the company focuses on the production of finished dosage forms, including tablets, capsules, and granules, across multiple therapeutic areas. Its product portfolio primarily consists of widely used generic medications such as Metformin for diabetes management, Paracetamol for pain and fever relief, and various vitamin supplements. The company operates GMP-certified manufacturing facilities and contributes to the broader healthcare offerings of the Dirui Group, which is globally recognized for its in vitro diagnostic (IVD) solutions. Changchun Dirui Pharmaceutical serves the domestic Chinese market, providing essential medicines to healthcare providers and consumers. As part of a larger medical technology group, it benefits from integrated resources and a strong presence in the regional healthcare sector.